[3-[[methyl-[3-(2-oxochromen-7-yl)oxypropyl]amino]methyl]phenyl]N-cyclopentylcarbamate

ID: ALA5218447

PubChem CID: 168298066

Max Phase: Preclinical

Molecular Formula: C26H30N2O5

Molecular Weight: 450.54

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CN(CCCOc1ccc2ccc(=O)oc2c1)Cc1cccc(OC(=O)NC2CCCC2)c1

Standard InChI:  InChI=1S/C26H30N2O5/c1-28(14-5-15-31-22-12-10-20-11-13-25(29)33-24(20)17-22)18-19-6-4-9-23(16-19)32-26(30)27-21-7-2-3-8-21/h4,6,9-13,16-17,21H,2-3,5,7-8,14-15,18H2,1H3,(H,27,30)

Standard InChI Key:  ZXMQJWJQVOCYQO-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 33 36  0  0  0  0  0  0  0  0999 V2000
   -4.9534    1.0330    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2388    1.4454    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5269    1.0335    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5269    0.2083    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2370   -0.2034    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.9534    0.2046    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.6708   -0.2095    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -6.3884    0.2046    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.3884    1.0330    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.6708    1.4473    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.1057   -0.2094    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8096   -0.2057    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0923    0.2083    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3751   -0.2057    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6578    0.2083    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0595   -0.2057    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.7768    0.2083    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4941   -0.2057    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0595   -1.0340    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2115    0.2081    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9262   -0.2053    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9262   -1.0338    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2133   -1.4473    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4941   -1.0375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6436    0.2087    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.3609   -0.2053    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0781    0.2087    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.3609   -1.0336    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.7954   -0.2053    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.5517    0.1313    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.1057   -0.4839    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.6918   -1.2008    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.8820   -1.0287    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  2  0
  3  2  1  0
  4  3  2  0
  5  4  1  0
  1  6  1  0
  6  5  2  0
  6  7  1  0
  8  7  1  0
  9  8  1  0
 10  9  2  0
  1 10  1  0
  8 11  2  0
  4 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 16 19  1  0
 20 18  2  0
 21 20  1  0
 22 21  2  0
 23 22  1  0
 24 23  2  0
 18 24  1  0
 21 25  1  0
 25 26  1  0
 26 27  1  0
 26 28  2  0
 27 29  1  0
 30 29  1  0
 30 31  1  0
 31 32  1  0
 32 33  1  0
 33 29  1  0
M  END

Alternative Forms

  1. Parent:

    ALA5218447

    ---

Associated Targets(Human)

ACHE Tclin Acetylcholinesterase (18204 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
BCHE Tclin Butyrylcholinesterase (7174 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
BCHE Tclin Cholinesterases; ACHE & BCHE (1222 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Faah Anandamide amidohydrolase (3907 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 450.54Molecular Weight (Monoisotopic): 450.2155AlogP: 4.72#Rotatable Bonds: 9
Polar Surface Area: 81.01Molecular Species: BASEHBA: 6HBD: 1
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 8.60CX LogP: 4.28CX LogD: 3.06
Aromatic Rings: 3Heavy Atoms: 33QED Weighted: 0.38Np Likeness Score: -0.81

References

1. Zhang H, Wang Y, Wang Y, Li X, Wang S, Wang Z..  (2022)  Recent advance on carbamate-based cholinesterase inhibitors as potential multifunctional agents against Alzheimer's disease.,  240  [PMID:35858523] [10.1016/j.ejmech.2022.114606]

Source